imiglucerase: Clinical Trials

3 trials of imiglucerase, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 3

Follow imiglucerase: new trials by email Literature Review of imiglucerase trials Research Report on imiglucerase

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate Efficacy and Safety of Imiglucerase Treatment in Chinese Patients With Gaucher Disease Type Ⅲ
Cerezyme® / Imiglucerase - Gaucher's Disease
Phase 4CompletedSanofi122021-03-022025-09-15
Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease
Cerezyme - Gaucher Disease, Type 1, Cerebroside Lipidosis Syndrome
Phase 4CompletedGenzyme, a Sanofi Company952001-12-012015-04-03
A Multicenter Study of the Efficacy of Cerezyme in Testing Skeletal Disease in Patients With Type I Gaucher Disease.
Cerezyme (imiglucerase for injection) - Gaucher Disease Type I, Cerebroside Lipidosis Syndrome
Phase 4CompletedGenzyme, a Sanofi Company401997-12-012015-03-05

Conditions studied

Gaucher Disease (3)

Sponsors

Genzyme, a Sanofi Company (2)  ·  Sanofi (1)

Countries

United States (2)  ·  Brazil (1)  ·  Canada (1)  ·  China (1)  ·  Italy (1)  ·  Poland (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Edward Kaye, M.D. (1)